Venture Capital, Artificial Intelligence, Startup, Biotechnology, London.
of these molecules is largely artisanal and relies heavily on humans for both experimental design and execution. This dependence is often limiting because, as a species, we’re cognitively incapable of fully grasping the complexity of biological systems. As a consequence, the development of novel